-
Mashup Score: 6
Emphasizing precise terminology in clinical studies may improve the transparency and accuracy of information presented at oncology conferences.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems - 2 month(s) ago
Blood Cancer Journal – Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems - 2 month(s) ago
Blood Cancer Journal – Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems - 3 month(s) ago
Blood Cancer Journal – Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Check our @UAMSMyeloma publication: Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems @BloodCancerJnl #mmsm ➡️ https://t.co/suUiMxaYZU ⬆️ferritin is an independent risk factor for PFS&OS in transplant eligible&non-eligible pts https://t.co/zl5u577Mxd
-
-
Mashup Score: 19
Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.More than 15% of published abstracts from ASCO, ASH and European Society for Medical Oncology annual meetings used subjective minimizing
Source: www.healio.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32
Persistent Immune Effector Cell Associated Hematotoxicity (ICAHT) is a significant side effect of BCMA CAR T-Cell therapy in patients with relapsed multiple myeloma (MM). The use of stem cell boosts in ICAHT has been described, however studies have been limited by small patient numbers and short follow up. Herein, we report on our multi-institutional experience of ICAHT, defined by an absolute…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 33Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Maria-Victoria Mateos Hospital Universitario de Salamanca, Salamanca, Spain Maria-Victoria Mateos, Pawel Robak, Marek Hus, Zhongjun Xia, Vera Zherebtsova, Christopher Ward, P. Joy Ho, Roman Hajek, Kihyun Kim, Meletios A. Dimopoulos, Claudio Cerchione, Antonio Riccio, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Joanna Opalinska, Vania Hungria Hospital Universitario de Salamanca, Salamanca, Spain, Medical University of Lodz, Lodz, Poland, Samodzielny Publiczny Szpital
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 68
Addition of elotuzumab to RVd induction or consolidation and lenalidomide maintenance in patients with transplant-eligible newly diagnosed multiple myeloma did not provide clinical benefit. Elotuzumab-containing therapies might be reserved for patients with relapsed or refractory multiple myeloma.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2JAPA Academy Journal - 3 month(s) ago
Jordanian American Physician Academy Journal
Source: journal.japacademy.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 31Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Maria-Victoria Mateos Hospital Universitario de Salamanca, Salamanca, Spain Maria-Victoria Mateos, Pawel Robak, Marek Hus, Zhongjun Xia, Vera Zherebtsova, Christopher Ward, P. Joy Ho, Roman Hajek, Kihyun Kim, Meletios A. Dimopoulos, Claudio Cerchione, Antonio Riccio, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Joanna Opalinska, Vania Hungria Hospital Universitario de Salamanca, Salamanca, Spain, Medical University of Lodz, Lodz, Poland, Samodzielny Publiczny Szpital
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
Subjective Language May Muddle Data Interpretation in Oncology Conferences @CancerNetwrk #mmsm @UAMSMyeloma https://t.co/JZ1sR1GAZX